Veradigm | MDRX - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Alcidion AUD 89.64M 1.84M 2025-12
Ambu A/S DKK 6.1B 65M 2026-03
Amplifon EUR 1.51B 436.98M 2026-06
Cardinal Health USD -2.88B 51M 2026-06
Centene USD 22.56B 1.14B 2026-06
Charles River Laboratories USD 2.84B 59.06M 2026-06
Cigna USD 42.62B 410M 2026-06
Coloplast 13.8B 2.32B 2025-12
Convatec Group USD 1.69B 34M 2024-12
CVS Health USD 79.7B 2.25B 2026-06
Diasorin EUR 1.53B 151.64M 2025-06
Elevance Health USD 44.88B 981M 2026-06
General Electric Aerospace USD 17.64B 417M 2026-06
Gulf Medical Proj AED 1.09B 135.31M 2026-03
Humana USD 19.21B 633M 2026-06
IQVIA Holdings USD 6.17B 50M 2026-06
Laboratory Of America USD 8.61B 121.8M 2026-06
Maximus USD 1.74B 43.59M 2026-06
McKesson USD -4.24B 2.07B 2026-06
Med Life RON 568M 84.24M 2026-03
Molina Healthcare USD 4.17B 91M 2026-06
Omnicell USD 1.29B 34.97M 2026-06
Oriola-kd EUR 92.8M 8M 2026-03
Owens Minor USD -550.94M 86.17M 2026-06
Quest Diagnostics USD 7.52B 150M 2026-06
Rede D'or Sao Luiz BRL 20.73B 1.6B 2026-06
Siemens Healthineers EUR 19.1B 889M 2026-06
Sonova Holding CHF 2.66B 374.5M 2025-06
Supermax Corporation Bhd MYR 3.77B 44.17M 2026-03
UnitedHealth USD 105.32B 3.62B 2026-03
Veeva Systems USD 7.3B 89.6M 2026-03
Veradigm USD 1.02B 159.52M 2022-12
Xerox USD 323M 24M 2026-06